A new trading day began on Tuesday, with Vir Biotechnology Inc (NASDAQ: VIR) stock price up 3.88% from the previous day of trading, before settling in for the closing price of $6.19. VIR’s price has ranged from $4.16 to $14.45 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -18.74% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 15.15%. With a float of $92.12 million, this company’s outstanding shares have now reached $138.89 million.
In an organization with 408 employees, it is important to assess its efficiency.
Vir Biotechnology Inc (VIR) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 33.69%, while institutional ownership is 56.98%. The most recent insider transaction that took place on Oct 27 ’25, was worth 401,585. In this transaction 10% Owner of this company sold 66,403 shares at a rate of $6.05, taking the stock ownership to the 14,598,536 shares. Before that another transaction happened on Oct 24 ’25, when Company’s 10% Owner sold 46,696 for $5.96, making the entire transaction worth $278,285. This insider now owns 14,664,939 shares in total.
Vir Biotechnology Inc (VIR) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.56 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.25% during the next five years compared to -18.74% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Here are Vir Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 47.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.01, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -2.81 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Let’s dig in a bit further. During the last 5-days, its volume was 2.0 million. That was better than the volume of 1.55 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 63.06%.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 94.79%, which indicates a significant increase from 85.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.33 in the past 14 days, which was higher than the 0.29 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.39, while its 200-day Moving Average is $6.28. However, in the short run, Vir Biotechnology Inc’s stock first resistance to watch stands at $6.61. Second resistance stands at $6.79. The third major resistance level sits at $7.02. If the price goes on to break the first support level at $6.19, it is likely to go to the next support level at $5.96. Assuming the price breaks the second support level, the third support level stands at $5.78.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
With a market capitalization of 893.23 million, the company has a total of 138,916K Shares Outstanding. Currently, annual sales are 74,210 K while annual income is -521,960 K. The company’s previous quarter sales were 1,210 K while its latest quarter income was -110,960 K.
